Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03793257 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The EXCEL Registry of Patients Requiring ECMO

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: 2000 to 3000v8 Show 6 more changesShow less
    • Primary completion date: Dec 22, 2023 to Dec 31, 2026
    • Study sites: 31 to 29
    • Study completion date: Dec 20, 2024 to Dec 31, 2027
    • Secondary endpoints revised (14)
    • Publications: 4 to 6
    • Eligibility criteria shortened, about 5 words
  2. Enrollment target: 525 to 2000
    • Primary completion date: Mar 31, 2022 to Dec 22, 2023
    • Study sites: 29 to 31
    • Study completion date: Sep 30, 2023 to Dec 20, 2024
    v7
  3. Re-verified, no change to tracked fieldsv6
  4. Primary endpoint revisedv5 Show 6 more changesShow less
    • Study sites: 26 to 29
    • Eligibility criteria shortened, about 10 words
    • Secondary endpoints: 11 to 14
    • Study description shortened, about 69 words
    • Collaborators expanded, about 36 words
    • Study title shortened, about 10 words
  5. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 1 to 26
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Start date: Jan 1, 2019 to Feb 1, 2019v3
  2. Secondary endpoints revised (11)v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
ECMO is associated with significant costs, risks and requires specialist training and expertise. EXCEL is a novel, high-quality, detailed prospective registry of patients requiring ECMO in Australia and New Zealand. The registry provides information on patient selection, complications, costs and patient reported outcome measures. EXCEL uses the Theoretical Domains Framework to identify evidence-practice gaps and explore barriers and enablers to tailor implementation of evidence
Trial Details
NCT Number NCT03793257
Lead Sponsor Australian and New Zealand Intensive Care Research Centre
Collaborators: National Health and Medical Research Council, Australia, Extracorporeal Life Support Organization, National Heart Foundation, Australia, The Alfred, Barwon Health, Fiona Stanley Hospital, The Prince Charles Hospital, Royal Prince Alfred Hospital, Sydney, Australia, St Vincent's Hospital, Sydney
Conditions
(from sponsor)		 Critically Ill, Acute Respiratory Failure, Acute Heart Failure, Cardiac Arrest
Related terms Critical Illness, Heart Arrest
Enrollment 3,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov